EXPERT COMMENT ON SMALLER COMPANIES AND AIM SHARES FOR INHERITANCE TAX PLANNING

CVS Group disappoints again, but is the sell-off overdone?

02/08/2018 · CVS Group (CVSG) 

Having reassured with a more positive trading update in January, shares in the UK’s leading veterinary group took another beating this week after a disappointing trading update. Is it time to give up on this hitherto high-flying cash machine, or keep the faith?

Sign up and read the full Blog

Register to continue reading this article.

Get FREE access now

Already a member? Login

Have your say

Log in or register to view or add comments.

Get free access now

Register free to gain access to more research

Register

Investor's Champion Premium Company Research

Subscribers to our Premium Company Research receive priority notification by email of newly published research. Premium company research costs as little as £3.20 per research note.

More on Premium Research

More on CVS Group

CVS Group disappoints again, but is the sell-off overdone?

02/08/2018 · Blog
Having reassured with a more positive trading update in January, shares in the UK’s leading veterinary…

Best of AIM shares 2017 - CVS Group: hero to villain - time to buy?

07/12/2017 · Premium Company Research

Why would the Chancellor attack AIM tax reliefs?

13/10/2017 · Blog
Investor’s Champion has researched AIM companies for over 12 years and has always highlighted the Inheritance…

AIM shares to avoid Inheritance Tax

21/12/2016 · Blog

This Blog explains how you can avoid inheritance tax and also boost your investment returns. Over…


Another good week for small caps as quality stocks keep on rising - our Blogs offer more!

04/12/2015 · Blog

​As Christmas draws near, the week saw plenty of excitement from the small cap world including…


More from the Blog

As the new football season kicks off and Arsenal is snapped up, Tottenham Hotspur looks a bargain!

10/08/2018

July 2018 AIM new arrivals – an eclectic bunch of prospective high flyers 

Peer to peer lending – does the reward really outweigh the risk?

06/08/2018